Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 146 results found. Search for [ Sputnik V efficacy ]

Results 1 to 21 of 146
BusinessToday.In
New Delhi, May 7, 2021
State-run lenders will take a lead in creation of the bad bank, but the sick asset resolution platform needs the support of private banks and other lenders to be successful, said State Bank of India Managing Director Swaminathan; India has welcomed the US support for a relaxation in the norms of the TRIPS (Trade-Related Aspects of Intellectual Property Rights) agreement to ensure quick and affordable access to Covid-19 vaccines and medicines for developing countries; Jindal Steel and Power Ltd (JSPL) said it has ramped up its daily oxygen supply limit to 120 tonne/day for the treatment of COVID-19 patients. Watch this and more news on News Blast.Also Read: Covid second wave to have muted impact on economy: Finance Ministry


Rashi Bisaria
New Delhi, May 7, 2021
COVID-19 in India: Centre issues guidelines for vaccination of aviation staffThe Centre on Thursday, issued an advisory to facilitate swift COVID-19 vaccination of aviation personnel working in government as well as private entities. As per the guidelines, civil aviation community provided unhindered services for the movement of people in need and essential cargo including critical medical cargo like vaccines, medicines, Oxygen Concentrators, etc., thus their vaccination remains a priority....


Vivek Dubey
May 6, 2021
\"The cost of the Sputnik Light vaccine globally will be less than $10 [around Rs 730], while it has simple storage requirements, at 2-8 degrees Celsius, which provide for easy logistics\"


BusinessToday.In
April 28, 2021
\"Initial positive neutralisation studies of B.1.617, with both post-Covaxin or Covishield sera, are correlatable with milder disease during post-vaccination breakthrough infections,\" says Anurag Agrawal, Director, Institute of Genomics and Integrative Biology


BusinessToday.In
April 25, 2021
The Hyderabad-based vaccine manufacturer has submitted updated accelerated and real-time stability data of Coaxin along with the justification for the extension of shelf life


BusinessToday.In
April 14, 2021
Coronavirus vaccination: After taking the first shot, the vaccine beneficiary will receive a message on his/her registered mobile number about the link to download the vaccination certificate


Reuters
April 14, 2021
The vaccine maker said the six-month follow-up of its original late-stage study of the vaccine showed that vaccine efficacy remained consistent with its previous updates


BusinessToday.In
April 13, 2021
Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses


BusinessToday.In
April 13, 2021
India is the leading production hub for Sputnik V. RDIF has signed pacts with Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech to produce over 850 million doses per year


BusinessToday.In
New Delhi, April 12, 2021
Russia's Sputnik V COVID-19 vaccine, with an effectiveness of 91.6 per cent, has been approved for restricted use in India, sources within the drug regulator's office confirmed the development on Monday. The approval to the vaccine was given based on 'very strong immunogenicity data'. Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. The vaccine demonstrated an efficacy rate of 91.6 per cent in the interim analysis of the phase 3 clinical trial in Russia. In February 2021, Dr Reddy's applied for the emergency use of the Russian vaccine in India. Watch the video for more.Also Read: Russia's COVID-19 vaccine Sputnik V gets govt's nod


BusinessToday.In
April 12, 2021
Developed by Russia's Gamaleya national center of epidemiology and microbiology, Sputnik V is the third COVID-19 vaccine approved by the Subject Expert Committee (SEC) after Covishield and Covaxin


BusinessToday.In
April 12, 2021
Of around 20 coronavirus vaccines in several clinical and pre-clinical stages, Russia's Sputnik V may get SEC's nod first


Reuters
April 12, 2021
The currently available vaccines \"don't have very high rates of protection\", said Gao Fu, the director of the Chinese Centers for Disease Control and Prevention


BusinessToday.In
April 11, 2021
Russian Direct Investment Fund (RDIF) has tied up with a host of Indian pharma companies such as Dr Reddy's Laboratories, Hetero Biopharma, Gland Pharma, Stelis Biopharma and Vichrow Biotech for the production of Sputnik V


PTI
April 9, 2021
Citing officials, Geo News reported that the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to another Chinese vaccine, CoronaVac


BusinessToday.In
April 6, 2021
Share of the pharma firm rose 19.99% to Rs 220.85 against previous close of Rs 184.40 on BSE. The stock opened with a gain of 15.68% at Rs 212.90


BusinessToday.In
April 5, 2021
Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF.


Reuters
March 30, 2021
The risk of infection fell 90% by two weeks after the second shot, the study of nearly 4,000 US healthcare personnel and first responders found


PTI
March 29, 2021
Deepak Sapra, Dr Reddy's CEO, APIs and Services, said the data on trials is currently with the Indian regulator and the company expects it to get approved in the next few weeks


BusinessToday.In
March 24, 2021
Already the Russian Direct Investment Fund, the force behind the Russian vaccine, has signed deals with several Indian companies for the production and distribution of Sputnik V


PAGES 1 OF 8  12345